People · Operator
Named in public records as an officer, director or promoter · active 2021–2021 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Zylo Therapeutics Inc. | — | Pharmaceuticals | Series A | $10.9M | $30.1M | 2021 |
Matt MICHAEL Dunbar at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Matt MICHAEL Dunbar on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| LANCE MICHAEL WHITE | 1 | 1 |
| James MICHAEL Cordes | 1 | 1 |
| SCOTT RUTLEDGE PANCOAST | 1 | 1 |
| GARY J. ATKINSON | 1 | 1 |
| Charles E. Hinkle | 1 | 1 |
| MICHAEL ZVI RABIN | 1 | 1 |
| Thomas Patrick Murray | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.